Your shopping cart is currently empty

Aflatoxin Q1, a hydroxy metabolite of Aflatoxin B1 (AFB1)—a mycotoxin synthesized by Aspergillus flavus (A. flavus)—and aflatoxin B1 8,9-oxide are principal oxidative derivatives produced from Aflatoxin B1 in human liver microsomes across all substrate concentrations. The conversion of Aflatoxin B1 to Aflatoxin Q1 through 3 alpha-hydroxylation represents a critical detoxification route [1] [2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | Inquiry | 3-6 months | 3-6 months | |
| 50 mg | Inquiry | 3-6 months | 3-6 months | |
| 100 mg | Inquiry | 3-6 months | 3-6 months |
| Description | Aflatoxin Q1, a hydroxy metabolite of Aflatoxin B1 (AFB1)—a mycotoxin synthesized by Aspergillus flavus (A. flavus)—and aflatoxin B1 8,9-oxide are principal oxidative derivatives produced from Aflatoxin B1 in human liver microsomes across all substrate concentrations. The conversion of Aflatoxin B1 to Aflatoxin Q1 through 3 alpha-hydroxylation represents a critical detoxification route [1] [2]. |
| Molecular Weight | 328.27 |
| Formula | C17H12O7 |
| Cas No. | 52819-96-2 |
| Smiles | O(C)C=1C2=C(C3=C(C1)O[C@@]4([C@]3(C=CO4)[H])[H])OC(=O)C5=C2[C@@H](O)CC5=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.